Measurement of cumulative radiation exposure to children and adolescents in contact with outpatients treated with low dose radioactive iodine (131I)

Author:

Salman Khaled,Wagieh Shereen,Bakhsh Aquib,Al-Monshy Tarek,Talaat Omnia,Al-Malki Musaed,Al-Ezzi Manal,Fouda Ashraf,Hamid Gihad

Abstract

Abstract Background Radiation exposure from patients treated with radioactive iodine (131I) represents a radiation hazard to children and adolescents, representing the most vulnerable group of household contacts. Our aim was to calculate the cumulative radiation exposure (CRE) figures to children and adolescents sharing the same home with outpatients treated with low-dose 131I. The secondary aim was to study the demographic and educational factors that may significantly affect radiation exposure to them. Results The whole number of household contacts less than 18 years was 99, out of them 49 ≤ 12 years. CRE level to children and adolescents ranged from 79 to 934 uSv. The mean, median, and 75th percentile figures were 284 ± 178 uSv, 215 uSv, and 334 uSv, respectively. The compliance of this group of contacts to radiation exposure constraint (1 mSv) was 100%. All CRE values were below this figure with 75% of them below half of this constraint. Thirteen adolescents from 12 to 18 years and 17 mothers of 23 household contacts ≤ 12 years got radiation safety instructions (RSI) directly from a radiation safety officer (RSO). This group had a significantly lower mean CRE value (184 ± 93 uSv) compared to those who got RSI from the patient or from other family members (298 ± 185 uSv) with a significant p value. Conclusion The compliance of adolescents and children to the 1-mSv radiation exposure constraint is 100%. It is advised for adolescents and mothers of children in contact with 131I-treated patients to get direct RSI from the RSO, which is the only factor associated with significantly lower radiation exposure figures.

Funder

King Abdulaziz City for Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Reference30 articles.

1. de Klerk JMH. 131I therapy: inpatient or outpatient? Nucl Med. 2000;41(11):1876–8.

2. Shinto SA, Kamaleshwaran KK, Shibu KD, Vyshak K, Antony J. Empiric therapy with low-dose I-131 in differentiated cancer thyroid: what is the magic number? World J Nucl Med. 2013;12(2):61–4.

3. NCRP Report No.155. Management of radionuclide therapy patients. Bethesda: National Council on Radiation Protection and Measurements (NCRP); 2006. https://ncrponline.org/shop/reports/report-no-155-management-of-radionuclide-therapy-patients-2006/. Accessed 1 Nov 2018

4. Uslu-Besli L, Demir M, Yweyin N, Cavdar I. Radiation dose of caregivers could be reduced in thyroid carcinoma patients requiring high dose of radioactive iodine: a case report. Iran J Nucl Med. 2016;24:144–6.

5. Wakeford R. The cancer epidemiology of radiation. Oncogene. 2004;23:6404–28.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3